Применение тамсулозина для профилактики развития острой задержки мочи в периоперационном периоде у пациентов хирургического профиля


DOI: https://dx.doi.org/10.18565/urology.2023.4.129-135

А.В. Говоров, А.Л. Саруханян

1) Кафедра урологии ФГБОУ ВО «МГМСУ им. А. И. Евдокимова» Министерства здравоохранения Российской Федерации, Москва, Россия; 2) ГБУЗ г. Москвы «ГКБ им. С. И.Спасокукоцкого» ДЗМ
Тактика ведения пациентов хирургического профиля в периоперационном периоде имеет множество особенностей. Одним из возможных осложнений разных операций является послеоперационная острая задержка мочи (ОЗМ). Для профилактики и лечения ОЗМ применяют препараты из группы α-адреноблокаторов. Тамсулозин – наиболее часто назначаемый α-адреноблокатор, применению которого у разных категорий пациентов посвящено большое число научных публикаций. Целью данного обзора литературы является оценка особенностей назначения тамсулозина в периоперационном периоде в качестве профилактики развития послеоперационной ОЗМ. Был проведен обзор опубликованной научной литературы в базах PubMed и Scopus с января 2013 по июнь 2023 г. По результатам обзора научной литературы, посвященной этой проблеме, выявлено достоверное снижение частоты развития ОЗМ в послеоперационном периоде при назначении тамсулозина. Персонализированный подход к применению тамсулозина до и после разных видов операций позволил оптимизировать периоперационное ведение пациентов и улучшить их качество жизни/удовлетворенность от лечения.
Ключевые слова: периоперационный период, острая задержка мочи, послеоперационный период, тамсулозин, профилактика
Полный текст статьи доступен
в "Библиотеке Врача"

Литература

1. Darrah D.M., Griebling T.L., Silverstein J.H. Postoperative urinary retention. Anesthesiol Clin. 2009 Sep;27(3):465–484, table of contents. Doi: 10.1016/j.anclin.2009.07.010.


2. Baldini G., Bagry H., Aprikian A., Carli F. Postoperative urinary retention: anesthetic and perioperative considerations. Anesthesiology. 2009 May;110(5):1139–1157. Doi: 10.1097/ALN.0b013e31819f7aea.


3. Liao L., Madersbacher H. (ed.). Neurourology: Theory and Practice. Springer, 2019. https://doi.org/10.1007/978-94-017-7509-0 Hardcover ISBN 978-94-017-7507-6, 583.


4. Matsuura S., Downie J.W. Effect of anesthetics on reflex micturition in the chronic cannula-implanted rat. Neurourol Urodyn. 2000;19(1):87–99. Doi: 10.1002/(sici)1520-6777(2000)19:1<87::aid-nau9>3.0.co;2-o.


5. Combrisson H., Robain G., Cotard J.P. Comparative effects of xylazine and propofol on the urethral pressure profile of healthy dogs. Am J Vet Res. 1993 Dec;54(12):1986–1989.


6. Petros J.G., Rimm E.B., Robillard R.J. Factors influencing urinary tract retention after elective open cholecystectomy. Surg Gynecol Obstet. 1992 Jun;174(6):497–500.


7. Kamphuis E.T., Ionescu T.I., Kuipers P.W., de Gier J., van Venrooij G.E., Boon T.A. Recovery of storage and emptying functions of the urinary bladder after spinal anesthesia with lidocaine and with bupivacaine in men. Anesthesiology. 1998 Feb;88(2):310–316. Doi: 10.1097/00000542-199802000-00007.


8. Mulroy M.F., Salinas F.V., Larkin K.L., Polissar N.L. Ambulatory surgery patients may be discharged before voiding after short-acting spinal and epidural anesthesia. Anesthesiology. 2002 Aug;97(2):315–319. Doi: 10.1097/00000542-200208000-00005.


9. Ryan J.A. Jr, Adye B.A., Jolly P.C., Mulroy M.F. 2nd. Outpatient inguinal herniorrhaphy with both regional and local anesthesia. Am J Surg. 1984 Sep;148(3):313–316. Doi: 10.1016/0002-9610(84)90461-6.


10. Bowen J.R., Thompson W.R., Dorman B.A., Soderberg C.H. Jr, Shahinian T.K.Change in the management of adult groin hernia. Am J Surg. 1978 Apr;135(4):564–569. Doi: 10.1016/0002-9610(78)90038-7.


11. Petros J.G., Mallen J.K., Howe K., Rimm E.B., Robillard R.J. Patient-controlled analgesia and postoperative urinary retention after open appendectomy. Surg Gynecol Obstet. 1993 Aug;177(2):172–175.


12. Gerstenberg T.C., Nielsen M.L., Clausen S., Blaabjerg J., Lindenberg J. Bladder function after abdominoperineal resection of the rectum for anorectal cancer. Urodynamic investigation before and after operative in a consecutive series. Ann Surg. 1980 Jan;191(1):81–86. Doi: 10.1097/00000658-198001000-00016.


13. Keita H., Diouf E., Tubach F., Brouwer T., Dahmani S., Mantz J., Desmonts J.M.Predictive factors of early postoperative urinary retention in the postanesthesia care unit. Anesth Analg. 2005 Aug;101(2):592–596. Doi: 10.1213/01.ANE.0000159165.90094.40.


14. Hansen B.S., Søreide E., Warland A.M., Nilsen O.B. Risk factors of post-operative urinary retention in hospitalised patients. Acta Anaesthesiol Scand. 2011 May;55(5):545–548. Doi: 10.1111/j.1399-6576.2011.02416.x. Epub 2011 Mar 21.


15. Dreijer B., Møller M.H., Bartholdy J. Post-operative urinary retention in a general surgical population. Eur J Anaesthesiol. 2011 Mar;28(3):190–194. Doi: 10.1097/EJA.0b013e328341ac3b.


16. Tammela T., Kontturi M., Lukkarinen O. Postoperative urinary retention. I. Incidence and predisposing factors. Scand J Urol Nephrol. 1986;20(3):197–201. Doi: 10.3109/00365598609024494.


17. Tammela T., Kontturi M., Lukkarinen O. Postoperative urinary retention. II. Micturition problems after the first catheterization. Scand J Urol Nephrol. 1986;20(4):257–260. Doi: 10.3109/00365598609024508.


18. Wong M.C., Isaacson K., Morris S. Into the void: a review of postoperative urinary retention after minimally invasive gynecologic surgery. Curr Opin Obstet Gynecol. 2018 Aug;30(4):260–266. Doi: 10.1097/GCO.0000000000000465.


19. Bracey D.N., Barry K., Khanuja H.S., Hegde V. Postoperative Urinary Retention in Modern Rapid Recovery Total Joint Arthroplasty. J Am Acad Orthop Surg. 2022 May 15;30(10):443–447. Doi: 10.5435/JAAOS-D-21-00963. Epub 2022 Feb 24.


20. Cataldo P.A., Senagore A.J. Does alpha sympathetic blockade prevent urinary retention following anorectal surgery? Dis Colon Rectum. 1991 Dec;34(12):1113–1116. Doi: 10.1007/BF02050073.


21. Petros J.G., Bradley T.M. Factors influencing postoperative urinary retention in patients undergoing surgery for benign anorectal disease. Am J Surg. 1990 Apr;159(4):374–376. Doi: 10.1016/s0002-9610(05)81274-7.


22. Bowers F.J., Hartmann R., Khanduja K.S., Hardy T.G. Jr, Aguilar P.S., Stewart W.R. Urecholine prophylaxis for urinary retention in anorectal surgery. Dis Colon Rectum. 1987 Jan;30(1):41–42. Doi: 10.1007/BF02556921.


23. Zaheer S., Reilly W.T., Pemberton J.H., Ilstrup D. Urinary retention after operations for benign anorectal diseases. Dis Colon Rectum. 1998 Jun;41(6):696–704. Doi: 10.1007/BF02236255.


24. Toyonaga T., Matsushima M., Sogawa N., Jiang S.F., Matsumura N., Shimojima Y., Tanaka Y., Suzuki K., Masuda J., Tanaka M. Postoperative urinary retention after surgery for benign anorectal disease: potential risk factors and strategy for prevention. Int J Colorectal Dis. 2006 Oct;21(7):676–682. Doi: 10.1007/s00384-005-0077-2. Epub 2006 Mar 22.


25. Pavlin D.J., Pavlin E.G., Fitzgibbon D.R., Koerschgen M.E., Plitt T.M. Management of bladder function after outpatient surgery. Anesthesiology. 1999 Jul;91(1):42–50. Doi: 10.1097/00000542-199907000-00010.


26. Petros J.G., Rimm E.B., Robillard R.J., Argy O. Factors influencing postoperative urinary retention in patients undergoing elective inguinal herniorrhaphy. Am J Surg. 1991 Apr;161(4):431–433; discussion 434. Doi: 10.1016/0002-9610(91)91105-r.


27. Goldman G., Leviav A., Mazor A., Kashtan H., Aladgem D., Greenstein A., Wiznitzer T. Alpha-adrenergic blocker for posthernioplasty urinary retention. Prevention and treatment. Arch Surg. 1988 Jan;123(1):35-6. doi: 10.1001/archsurg.1988.01400250037005.


28. Demirel A., Polat O., Siyez E., Bayraktar Y. Urinary retention after renal and ureteric surgery. Br J Urol. 1993 Jul;72(1):54–55. Doi: 10.1111/j.1464-410x.1993.tb06457.x.


29. Davies A.H., Cranston D. Urinary retention after pyeloplasty. Br J Urol. 1991 May;67(5):456–458. Doi: 10.1111/j.1464-410x.1991.tb15186.x.


30. Gönüllü N.N., Gönüllü M., Utkan N.Z., Dülger M., Gökgöz S., Karsli B. Postoperative retention of urine in general surgical patients. Eur J Surg. 1993 Mar;159(3):145–147.


31. Boyle P. Some remarks on the epidemiology of acute urinary retention. Arch Ital Urol Androl. 1998 Apr;70(2):77–82.


32. Geller E.J. Prevention and management of postoperative urinary retention after urogynecologic surgery. Int J Womens Health. 2014 Aug 28;6:829-38. doi: 10.2147/IJWH.S55383.


33. Kitada S., Wein A.J., Kato K., Levin R.M. Effect of acute complete obstruction on the rabbit urinary bladder. J Urol. 1989 Jan;141(1):166–169. Doi: 10.1016/s0022-5347(17)40633-1.


34. Platt R., Polk B.F., Murdock B., Rosner B. Mortality associated with nosocomial urinary-tract infection. N Engl J Med. 1982 Sep 9;307(11):637–642. Doi: 10.1056/NEJM198209093071101.


35. Niël-Weise B.S., van den Broek P.J. Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004203. doi: 10.1002/14651858.CD004203.pub2. Update in: Cochrane Database Syst Rev. 2015;12:CD004203.


36. Papageorge C.M., Howington B., Leverson G., Kennedy G.D., Carchman E.H.Preoperative Tamsulosin to Prevent Postoperative Urinary Retention: A Randomized Controlled Trial. J Surg Res. 2021 Jun;262:130–139. Doi: 10.1016/j.jss.2020.12.055. Epub 2021 Feb 6.


37. Lo E., Nicolle L.E., Coffin S.E., Gould C., Maragakis L.L., Meddings J., Pegues D.A., Pettis A.M., Saint S., Yokoe D.S. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014 May;35(5):464–479. Doi: 10.1086/675718.


38. Kachare S.D., Sanders C., Myatt K., Fitzgerald T.L., Zervos E.E. Toward eliminating catheter-associated urinary tract infections in an academic health center. J Surg Res. 2014 Dec;192(2):280–285. Doi: 10.1016/j.jss.2014.07.045. Epub 2014 Jul 24.


39. Benoist S., Panis Y., Denet C., Mauvais F., Mariani P., Valleur P. Optimal duration of urinary drainage after rectal resection: a randomized controlled trial. Surgery. 1999 Feb;125(2):135–141.


40. Lepor H., Tang R., Shapiro E. The alpha-adrenoceptor subtype mediating the tension of human prostatic smooth muscle. Prostate. 1993;22(4):301–307. Doi: 10.1002/pros.2990220404.


41. Hieble J.P., Bylund D.B., Clarke D.E., Eikenburg D.C., Langer S.Z., Lefkowitz R.J., Minneman K.P., Ruffolo R.R. Jr. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev. 1995 Jun;47(2):267–270.


42. Kojima Y., Sasaki S., Kubota Y., Imura M., Oda N., Kiniwa M., Hayashi Y., Kohri K. Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia. J Urol. 2011 Oct;186(4):1530–1536. Doi: 10.1016/j.juro.2011.05.048. Epub 2011 Aug 19.


43. Korstanje C., Krauwinkel W., van Doesum-Wolters F.L. Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity? Br J Clin Pharmacol. 2011 Aug;72(2):218–225. Doi: 10.1111/j.1365-2125.2010.03870.x.


44. Narayan P., Tewari A. A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia. United States 93-01 Study Group. J Urol. 1998 Nov;160(5):1701–1706.


45. Lepor H. Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group. Urology. 1998 Jun;51(6):892–900. Doi: 10.1016/s0090-4295(98)00126-5.


46. Nickel J.C., Sander S., Moon T.D. A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia. Int J Clin Pract. 2008 Oct;62(10):1547–1559. doi: 10.1111/j.1742-1241.2008.01880.x.


47. O’Leary M.P. Tamsulosin: current clinical experience. Urology. 2001 Dec;58(6 Suppl 1):42-8; discussion 48. Doi: 10.1016/s0090-4295(01)01346-2.


48. Pummangura N., Kochakarn W. Efficacy of tamsulosin in the treatment of lower urinary tract symptoms (LUTS) in women. Asian J Surg. 2007 Apr;30(2):131–137. Doi: 10.1016/S1015-9584(09)60146-9.


49. Kim S.O., Hwang E.C., Oh K.J., Kwon D., Park K., Ryu S.B. Efficacy and safety of combined therapy with tamsulosin and tolterodine in female patients with a maximal flow rate less than 12 ml/s. Int Urogynecol J. 2011 Oct;22(10):1287–1291. Doi: 10.1007/s00192-011-1453-9.


50. Hajebrahimi S., Asrbadr Y.A., Azaripour A., Sadeghi-Bazargani H. Effect of tamsulosin versus prazosin on clinical and urodynamic parameters in women with voiding difficulty: a randomized clinical trial. Int J Gen Med. 2011 Jan 11;4:35–39. Doi: 10.2147/IJGM.S16063.


51. Ghuman A., Dawidek M.T., Athwal M.S., Kasteel N., Brown C.J., Karimud-din A.A., Raval M.J., Phang P.T. Prophylactic tamsulosin and urinary retention rates following elective colorectal surgery: a retrospective cohort study. Int J Colorectal Dis. 2022 Jan;37(1):209–214. Doi: 10.1007/s00384-021-04047-w.


52. Choi C.I., Kim J.K., Choo M.S., Lee S.H., Chang J.D., Han J.H. Preventive effects of tamsulosin for postoperative urinary retention after lower limb arthroplasty: A randomized controlled study. Investig Clin Urol. 2021 Sep;62(5):569–576. Doi: 10.4111/icu.20200523.


53. Chapman G.C., Sheyn D., Slopnick E.A., Roberts K., El-Nashar S.A., Henderson J.W., Mangel J., Hijaz A.K., Pollard R.R., Mahajan S.T. Tamsulosin vs placebo to prevent postoperative urinary retention following female pelvic reconstructive surgery: a multicenter randomized controlled trial. Am J Obstet Gynecol. 2021 Sep;225(3):274.e1–274.e11. Doi: 10.1016/j.ajog.2021.04.236


54. Jeong I.G., You D., Yoon J.H., Hong S., Lim J.H., Hong J.H., Choo M.S., Ahn H., Kim C.S. Impact of tamsulosin on urinary retention following early catheter removal after robot-assisted laparoscopic radical prostatectomy: a prospective randomized controlled trial. Int J Urol. 2014 Feb;21(2):164–168. Doi: 10.1111/iju.12225.


55. Poylin V., Curran T., Cataldo T., Nagle D. Perioperative use of tamsulosin significantly decreases rates of urinary retention in men undergoing pelvic surgery. Int J Colorectal Dis. 2015 Sep;30(9):1223–1228. Doi: 10.1007/s00384-015-2294-7.


56. Li H., Zhang W., Xu G., Wang D., Xu C., Zhang H., Zhang L., Li J., Tang P.Prophylactic tamsulosin can reduce the risk of urinary retention after surgery in male patients: A systematic review and meta-analysis. Front Surg. 2022 Nov 10; 9:930707. Doi: 10.3389/fsurg.2022.930707.


57. Gao B., Zhang D., Wang Y., Wang Z., Wang Z. The effect of tamsulosin in postoperative urinary retention: a meta-analysis of randomized controlled trials. Naunyn Schmiedebergs Arch Pharmacol. 2023 Mar;396(3):441–451. Doi: 10.1007/s00210-022-02343-y.


58. Zhou Z., Gan W., Li Z., Li Z., Zhou F., Li H., Liu Z. Can prophylactic tamsulosin reduce the risk of urinary retention after surgery? A systematic review and meta-analysis of randomized control trials. Int J Surg. 2023 Mar 1;109(3):438–448. Doi: 10.1097/JS9.0000000000000267.


59. Jang J.H., Kang S.B., Lee S.M., Park J.S., Kim D.W., Ahn S. Randomized controlled trial of tamsulosin for prevention of acute voiding difficulty after rectal cancer surgery. World J Surg. 2012 Nov;36(11):2730–2737. Foi: 10.1007/s00268-012-1712-z.


60. Melnikov A.V. Postoperative urinary retention. Мельников А.В. Послеоперационная острая задержка мочеиспускания: автореферат дис. кандидата медицинских наук: 14.00.40. М., 2002.26 с.: ил. Режим доступа: https://www.dissercat.com/content/posleoperatsionnaya-ostraya-zaderzhka mocheispuskaniya?ysclid=ll1dsexxgf914031822


Об авторах / Для корреспонденции

А в т о р д л я с в я з и: А.В. Говоров – д.м.н., профессор РАН, профессор кафедры урологии ФГБОУ ВО «МГМСУ им. А.И. Евдокимова» МЗ РФ, ГБУЗ г. Москвы «ГКБ им. С. И. Спасокукоцкого» ДЗМ, Москва, Россия; e-mail: dr.govorov@gmail.com


Похожие статьи

К содержанию номера

Бионика Медиа